Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;126(12):1084-8.
doi: 10.1016/j.amjmed.2013.08.012.

'Race' and prostate cancer mortality in equal-access healthcare systems

Tisheeka Graham-Steed  1 , Edward Uchio, Carolyn K Wells, Mihaela Aslan, John Ko, John Concato
Affiliations
Review

'Race' and prostate cancer mortality in equal-access healthcare systems

Tisheeka Graham-Steed et al. Am J Med. 2013 Dec.

Abstract

Background: Reports suggest worse health-related outcomes among black (vs white) men diagnosed with prostate cancer, but appropriate cause-effect inferences are complicated by the relationship of race and other prognostic factors.

Methods: We searched the literature to find contemporary articles focusing on mortality among black and white men with prostate cancer in equal-access healthcare systems. We also directly assessed the association of race and prostate cancer mortality by conducting an observational cohort analysis of 1270 veterans diagnosed with prostate cancer and followed for 11 to 16 years at 9 medical centers within the Veterans Health Administration.

Results: Among 5 reports providing quantitative results for the association of race and mortality among men with prostate cancer in equal-access systems, outcomes were similar for black and white men. Race also was not a prognostic factor in the observational cohort analysis of US veterans, with an adjusted hazard ratio for black (vs white) men and prostate cancer mortality of 0.90 (95% confidence interval, 0.58-1.40; P = .65).

Conclusions: Mortality among black and white patients with prostate cancer is similar in equal-access healthcare systems. Studies that find racial differences in mortality (including cause-specific mortality) among men with prostate cancer may not account fully for socioeconomic and clinical factors.

Keywords: Delivery of health care; Ethnic groups; Healthcare disparities; Prostatic neoplasms; Race.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

References

    1. Brawley OW. Prostate cancer epidemiology in the United States. World J Urol. 2012;30:195–200. - PubMed
    1. Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001;93:388–395. - PubMed
    1. Taksler GB, Keating NL, Cutler DM. Explaining racial differences in prostate cancer mortality. Cancer. 2012;118:4280–4289. - PubMed
    1. Fowler JE, Jr, Bigler SA, Bowman G, Kilambi NK. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment. J Urol. 2000;163:137–142. - PubMed
    1. Powell IJ, Banerjee M, Novallo M, et al. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease. Urology. 2000;55:246–251. - PubMed

Publication types